Osaic Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Osaic Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38,505	Closed	-$45K	–	7652
2022 Q3	$45K	Buy	38,505 +237	+0.6%	+$369	﹤0.01%	5006
2022 Q2	$102K	Buy	38,268 +444	+1%	+$655	﹤0.01%	4413
2022 Q1	$14K	Buy	37,824 +8,739	+30%	+$17.2K	﹤0.01%	5959
2021 Q4	$89K	Sell	29,085 -13,485	-32%	-$49.8K	﹤0.01%	4681
2021 Q3	$189K	Buy	42,570 +4,430	+12%	+$21.3K	﹤0.01%	3957
2021 Q2	$221K	Buy	38,140 +4,346	+13%	+$25.5K	﹤0.01%	3788
2021 Q1	$239K	Buy	33,794 +6,228	+23%	+$41.8K	﹤0.01%	3579
2020 Q4	$132K	Sell	27,566 -21,938	-44%	-$111K	﹤0.01%	3841
2020 Q3	$304K	Buy	49,504 +11,548	+30%	+$69.1K	﹤0.01%	2868
2020 Q2	$255K	Buy	37,956 +9,441	+33%	+$71.5K	﹤0.01%	2919
2020 Q1	$188K	Buy	+28,515	New	+$229K	﹤0.01%	2917

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Osaic Holdings's CLVS Position: Q4 2022 in Review

Osaic Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 38,505 shares — an estimated $45K sold.

Osaic Holdings first reported a position in CLVS in Q1 2020 and held it in 11 quarters. The position peaked at $304K in Q3 2020. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Osaic Holdings reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 38,505 Clovis Oncology, Inc. shares in Q4 2022, an estimated $45K.
Osaic Holdings first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 11 quarters.
Osaic Holdings's Clovis Oncology, Inc. position peaked at $304K in Q3 2020.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.